Investigational Site Number 840008

Salt Lake City, Utah 84113

0 studies enrolling now · 2 studies all time

What they study most

Hypercholesterolaemia, Pompe Disease

Studies at this site

• Alglucosidase Alfa Pompe Safety Sub-Registry — Completed
• Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin) — Completed